About Pacific Diabetes Technologies
Pacific Diabetes Technologies is a company based in Portland (United States) founded in 2011.. Pacific Diabetes Technologies has raised $6.52 million across 10 funding rounds from investors including NIH, HHS and Cascadia Venture Forum. Pacific Diabetes Technologies offers products and services including SynerG. Pacific Diabetes Technologies operates in a competitive market with competitors including Admetsys, TypeZero Technologies, Cellnovo, Ideal Medical Technologies and Animas, among others.
- Headquarter Portland, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pacific Diabetes Technologies, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.52 M (USD)
in 10 rounds
-
Latest Funding Round
$2.92 M (USD), Series A
Oct 06, 2025
-
Investors
NIH
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pacific Diabetes Technologies
Pacific Diabetes Technologies offers a comprehensive portfolio of products and services, including SynerG. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A single device for continuous glucose monitoring and insulin site management.
Unlock access to complete
Unlock access to complete
Funding Insights of Pacific Diabetes Technologies
Pacific Diabetes Technologies has successfully raised a total of $6.52M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $2.92 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series A — $2.9M
-
First Round
First Round
(18 Sep 2012)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series A - Pacific Diabetes Technologies | Valuation |
investors |
|
| Mar, 2025 | Amount | Series A - Pacific Diabetes Technologies | Valuation |
investors |
|
| Sep, 2023 | Amount | Series A - Pacific Diabetes Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pacific Diabetes Technologies
Pacific Diabetes Technologies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Cascadia Venture Forum. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A charitable trust focused on healthcare and research funding.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pacific Diabetes Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pacific Diabetes Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pacific Diabetes Technologies Comparisons
Competitors of Pacific Diabetes Technologies
Pacific Diabetes Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Admetsys, TypeZero Technologies, Cellnovo, Ideal Medical Technologies and Animas, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of a closed-loop system for insulin and glucose delivery
|
|
| domain | founded_year | HQ Location |
Device for continuous glucose monitoring with manually operated insulin delivery
|
|
| domain | founded_year | HQ Location |
Offers online slot gaming with bonuses, promotions, and secure interface.
|
|
| domain | founded_year | HQ Location |
An AI-based artificial pancreas system is developed for ICU patients.
|
|
| domain | founded_year | HQ Location |
Device for continuous glucose monitoring with manual insulin administration
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pacific Diabetes Technologies
Frequently Asked Questions about Pacific Diabetes Technologies
When was Pacific Diabetes Technologies founded?
Pacific Diabetes Technologies was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Pacific Diabetes Technologies located?
Pacific Diabetes Technologies is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Is Pacific Diabetes Technologies a funded company?
Pacific Diabetes Technologies is a funded company, having raised a total of $6.52M across 10 funding rounds to date. The company's 1st funding round was a Series A of $1.54M, raised on Sep 18, 2012.
What does Pacific Diabetes Technologies do?
Pacific Diabetes Technologies (PDT) aims to create an accessible integrated artificial pancreas which is a result of sensor chemistry with microelectronic fabrication technologies. The device is intended to be used for Type 1 diabetes or insulin-treated Type 2 diabetes and as of Nov 2015, it is not approved for human use. The first device of the company performs glucose sensing and hormone delivery, consisting of an insertion tool, electronic sensor module, insulin infusion line connector, and sensing catheter sensor house. This system provides diabetes management solution as it combines multiple amperometric glucose sensing units with insulin delivery in a single unified device.
Who are the top competitors of Pacific Diabetes Technologies?
Pacific Diabetes Technologies's top competitors include Admetsys, TypeZero Technologies and Ideal Medical Technologies.
What products or services does Pacific Diabetes Technologies offer?
Pacific Diabetes Technologies offers SynerG.
Who are Pacific Diabetes Technologies's investors?
Pacific Diabetes Technologies has 4 investors. Key investors include NIH, HHS, Cascadia Venture Forum, and Helmsley Charitable Trust.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.